METABOLIC SYNDROME IN THE ELDERLY: AN OVERVIEW OF THE EVIDENCE

REFERENCES

• Grundy SM, CEeeman JI, Daniek SR, Donato KA, EckeE RH, Fran-klin BA. Diagnosis and management of the metabolic syndrome: an American Heart Association/NationaE Heart, Lung and !Mood Institute scientific statement. Circulation 2005; 112: 2735–52.
   PubMed Web of Science ®Google Scholar
• Reaven GM. RoFe of insulin resistance in human disease. Diabe-tes 1988:1595–607.
   Web of Science ®Google Scholar
• KapEan NM. The deaclly quartet: upper body obesity, gkicose into[erance, hypertrigEyceridemia and hypertension. Arch Intern Med 1989; 149:1514–20.
   Google Scholar
• Haffner S, VaEclez R, Hazuda H, Mitchell B, MoraFes P, Stern M. Prospective anaEysis of the insulin-resistance syndrome (syn-drome X). Diabetes 1992; 41:715–22.
   PubMed Web of Science ®Google Scholar
• Yudkin JS.AbnormaEities of coaguEation and fibrinoEysis in insu-lin resistance. Evidence for a common antecedent? Diabetes Care 1999; 22: 25–30.
   Google Scholar
• Malik S, Wong ND, Franklin SS. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascuEar disease, and all causes in United States adu Lis. Circulation 2004; 110: 1245–50.
   PubMed Web of Science ®Google Scholar
• Yavuz B, Kabakci G, Aksoy H, et al Determining the reEationship between metabolic syndrome score and angiographic severity of coronary artery disease. Intl Clin Pract 2008; 62: 717–22.
   Web of Science ®Google Scholar
• Lakka HM, Laaksonen DE, Lakka TA, et al The metabolic syndrome and totaE and cardiovascu Ear disease mortality in midclle-aged men. JAMA 2002; 288: 2709–16.
   PubMed Web of Science ®Google Scholar
• Reaven GM. The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1237–47.
   PubMed Web of Science ®Google Scholar
• Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European Group for the study of insulin resistance (EGIR). Diabet Med 1999; 16:442–3.
   PubMed Web of Science ®Google Scholar
• Balkau B, Charles MA, Drivsholm T, et al. Frequency of the WHO Metabolic syndrome in European Cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28; 364–76.
   PubMed Web of Science ®Google Scholar
• World health Organization. Definition, diagnosis, and classifica-tion of diabetes mellitus and its complications: Report of a WHO consultation, 1999. Part 1: Diagnosis and classification of dia-betes mellitus. Geneva, Switzerland: World Health Organization. 1999.
   Google Scholar
• Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–97.
   PubMed Web of Science ®Google Scholar
• Einhorn D, Reaven GM, Cobin RH, et al. American College of endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9:237–52.
   PubMedGoogle Scholar
• Alberti KG, Zimmet P, Shaw J, Epidemiology Task Force Consen-sus Group. The metabolic syndrome - a new worldwide defini-tion. Lancet 2005; 366: 1059–62.
   PubMed Web of Science ®Google Scholar
• AthyrosVG,Ganotakis ES, Elisaf M, Mikhailidis DP. The prevalence of the metabolic syndrome using the National Cholesterol Edu-cation program and International Diabetes Federation defini-tions. Cuff Med Res Opin 2005; 21: 1157–9.
   Web of Science ®Google Scholar
• Sandhofer A, Iglseder B, Paulweber B, Ebenbichler C, Patsch J. Comparison of different definitions of the metabolic syndrome. Eur Clin Invest 2007; 37:109–16.
   PubMed Web of Science ®Google Scholar
• Milionis Hi, Kostapanos MS, Liberopoulos EN, et al. Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjects. Intl Clin Pract 2007; 61:545–51.
   PubMed Web of Science ®Google Scholar
• Hanley A, Karter A, Williams K, et al. Prediction of type 2 diabe-tes mellitus with alternative definitions of the metabolic syn-drome; the insulin resistance atherosclerosis study. Circulation 2005: 112: 3713–21.
   PubMed Web of Science ®Google Scholar
• Cankurtaran M, Halil M, Yavuz B, Dagli N, Basak O, Ariogul S. Prevalence and correlates of metabolic syndrome (MS) in older adults. Arch Gerontol Geriatr 2006; 42: 35–45.
   Web of Science ®Google Scholar
• Gausse-Nilson S, Gherman D, Kumar D., Kennerfalk A, Steen B. Prevalence of the metabolic syndrome in an elderly Swedish population. Acta Diabetol 2006; 43: 120–6.
   Web of Science ®Google Scholar
• Maggi S, Noale M, Gallina P, et al. Metabolic syndrome, diabetes and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging. J Gerontol A Biol Sci Med Sci 2006; 61: 505–10.
   PubMed Web of Science ®Google Scholar
• Ravaglia G, Forti P, Maioli F, Bastalgi L. Metabolic syndrome: Prevalence and prediction of mortality in elderly individuals. Diabetes Care 2006; 29: 2471–6.
   PubMed Web of Science ®Google Scholar
• Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M. The metabolic syndrome predicts cardiovascular mortality:a 13-year follow-up in elderly non-diabetic Finns. Eur Heart J 2007; 28: 857–64.
   PubMed Web of Science ®Google Scholar
• Blaum C, West N, Haan M. Is the metabolic syndrome with or without diabetes associated with progressive disability in older Mexican Americans?J Gerontol A Biol Sci Med Sci 2007; 62: 766–73.
   Web of Science ®Google Scholar
• Choi K, Lee J, Lee K, et al. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol 2004; 61: 75–80.
   PubMed Web of Science ®Google Scholar
• He Y, Jiang B, Wang J, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006; 47: 1588–94.
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Ohtsuka N, Ninomiya D, Nakamura S. Carotid Atherosclerosis in Normal-Weight Metabolic Syndrome. Intern Med 2007; 46:1771–7.
   Web of Science ®Google Scholar
• Lai S, Liao K, Li T, Lin H, Lin W, Lin C. Metabolic syndrome in older people in Taiwan: a hospital-based study. Intern Med J 2006; 36:648–51.
   PubMed Web of Science ®Google Scholar
• McNeill A, Katz R, Girman C, et al. Metabolic syndrome and cardiovascular disease in older people. J Am Geriatr Soc 2006; 54: 1317–24.
   PubMed Web of Science ®Google Scholar
• Muller M, Tang H, Schupf N, Manly J, Mayeux R, Luchsinger J. Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 2007; 24: 185–92.
   PubMed Web of Science ®Google Scholar
• Otiniano M, Du X, Maldonado M, Ray L, Markides K. Effect of metabolic syndrome on heart attack and mortality in Mexican-American elderly persons: findings of 7-year follow-up from the Hispanic Established Population for the Epidomiological Study for the Elderly. J Gerontol 2005; 60: 466–70.
   Google Scholar
• Roriz-Cruz M, Rosset I, Wada T. Stroke-independent association between metabolic syndrome and functional dependence, de-pression and low quality of life in elderly community-dwelling Brazilian people. J Am Geriatr Soc 2007; 55: 374–82.
   PubMed Web of Science ®Google Scholar
• Scuteri A, Najjar S, Morell C, Lakatta E. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events. Diabetes Care 2002; 28: 882–7.
   Google Scholar
• Kuzuya M, Ando F, Iguchi A, Shimokata H. Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort. Atherosclerosis 2007; 191: 305–12.
   PubMed Web of Science ®Google Scholar
• Bonora E, Kiechl S, Willeit J, et al. Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003; 26: 1251–7.
   PubMed Web of Science ®Google Scholar
• Meigs JB, Wilson PWF, Nathan DM, D'Agostino R, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring studies. Diabetes 2003; 52: 2160–7.
   PubMed Web of Science ®Google Scholar
• Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003; 26: 575–81.
   PubMed Web of Science ®Google Scholar
• Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of meta-bolic syndrome in an urban population:Tehran lipid and glucose study. Diab Res Clin Pract 2003; 61: 29–37.
   PubMed Web of Science ®Google Scholar
• Gu D, Reynolds K, Wu X, et al. Prevalence of the metabolic syn-drome and overweight among adults in China. Lancet 2005; 365: 1398–405.
   PubMed Web of Science ®Google Scholar
• Trevisian M, Liu J, Bahsas F, Menotti A. Syndrome X and mortal-ity: a population based study. Am Journal Epidemiol 1998; 148: 958–66.
   Web of Science ®Google Scholar
• Chuang SCC, Tsai S, Chou P. Clinical identification of the meta-bolic syndrome in Kinmen. Acta Cardiol Sin 2002; 18:16–23.
   Google Scholar
• Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabe-tes Care 2001; 24:683–9.
   PubMed Web of Science ®Google Scholar
• Gu D, Reynolds K, Wu X. Prevalence, awareness, treatment and control of hypertension in China. Hypertension 2002; 40: 920–7.
   PubMed Web of Science ®Google Scholar
• Zhou BF. Effect of the body mass index on all-cause mortality and incidence of cardiovascular diseases - report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci 2002; 15: 245–52.
   PubMed Web of Science ®Google Scholar
• Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organisation metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart study. Circulation 2004; 110: 1251–7.
   PubMed Web of Science ®Google Scholar
• McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 385–90.
   PubMed Web of Science ®Google Scholar
• Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-agedmen. JAMA 2002; 288:2709–16
   PubMed Web of Science ®Google Scholar
• Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American
   Google Scholar
• Ford E. Risks for all-cause mortality, cardiovascular disease and diabetes associated with the metabolic syndrome. Diabetes Care 2005; 28: 1769–78.
   PubMed Web of Science ®Google Scholar
• Institute of Medicine. In: Pope AM, Tarlov AR, eds. Disability in America: toward a national agenda for prevention. Washington, DC: National Academy Press. 1991.
   Google Scholar
• Visser M, Langlos J, Guralnik J M. High body fatness but not low fat-free mass, predict disability in older men and women: the Cardiovascular Heath Study. Am J Clin Nutr 1998; 68: 584–90.
   PubMed Web of Science ®Google Scholar
• Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752–61.
   PubMed Web of Science ®Google Scholar
• Gardner JP, Li S, Srinivasan SR, et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation 2005; 111: 2171–7.
   PubMed Web of Science ®Google Scholar
• Gregg EW. Diabetes and physical disability among older U.S. adults. Diabetes Care 2000; 23: 1272–7.
   PubMed Web of Science ®Google Scholar
• Carmelli D, Swan GE, Reed T, et al. Midlife cardiovascular risk factors and brain morphology in identical older male twins. Neurology 1999; 52: 1119–24.
   PubMed Web of Science ®Google Scholar
• Prins ND, van Dijk EJ, der Heijer T, et al. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005; 128: 2034–41.
   PubMed Web of Science ®Google Scholar
• Bang OY, Kim JW, Lee MA, et al. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005; 26: 296–8.
   Google Scholar
• Muldoon MF, Mackey RH, Korytkowski MT, et al. The metabolic syndrome is associated with reduced central serotonergic re-sponsivity in healthy community volunteers. J Clin Endocr Metab 2006; 91: 718–21.
   PubMed Web of Science ®Google Scholar
• Goldberg S, Smith GS, Barnes A, et al. Serotonin modulation of cerebral glucose metabolism in normal aging. Neurobiol Aging 2004; 25: 167–74.
   Web of Science ®Google Scholar
• Unwin N, Bhopal R, Hayes L, et al. A comparison of the new in-ternational diabetes federation definition of metabolic syn-drome to WHO and NCEP definitions in Chinese, European and South Asian origin adults. Ethn Dis 2007; 17:522–8.
   PubMed Web of Science ®Google Scholar
• De Silva DA, Woon FP, Xie XY, Li Hsian Chen C, Chang HM, Wong MC. Metabolic syndrome among ethnic South Asian patients with ischemic stroke and comparison with ethnic Chinese pa-tients: the Singapore General Hospital experience. J Stroke Cerebrovasc Dis 2007; 16:119–21.
   Google Scholar
• Tiffin T, Forouhi N, Johnston DG, McKeigue PM, Chaturvedi N, Godsland IF. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study. Diabetologia 2005 48: 649–56.
   Web of Science ®Google Scholar
• Ajjan R, Carter AM, Somani R, Kain K, Grant PJ. Ethnic differ-ences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome. J Thromb Haemost 2007; 5:754–60.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Hansen B, Smith SC Jr. Clinical management of metabolic syndrome: report of the American Hea rt Asscociation/ National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to manage-ment. Circulation 2004;109:551.
   PubMed Web of Science ®Google Scholar
• Meigs JB. The metabolic syndrome. BMJ 2003; 327: 61–2.
   PubMed Web of Science ®Google Scholar
• Ford S. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S. Dia-betes Care 2005; 28: 2745–9.
   PubMed Web of Science ®Google Scholar
• Hanson R, Imperatore G, Bennet P, Knowler W. Components of the metabolic syndrome and incidence of type 2 diabetes. Dia-betes 2002; 51: 3120–7.
   PubMed Web of Science ®Google Scholar
• Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr.2006; 83: 1248–51.
   Google Scholar
• Hanley A, Festa A, D'Agostino R. Metabolic and inflammation variable clusters and prediction of type 2 diabetes: factor analysis using directly measured insulin sensitivity. Diabetes 2004; 53:1773–81.
   PubMed Web of Science ®Google Scholar